Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Anavex Life Sciences Corp sell BiotechBee

Start price
€7.86
29.12.22 / 90%
Target price
€2.00
31.12.25
Performance (%)
-2.34%
End price
€7.68
05.05.23
Summary
This prediction ended on 05.05.23 with a price of €7.68. With a performance of -2.34%, the SELL prediction by BiotechBee was trending in the right direction. BiotechBee has 90% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Anavex Life Sciences Corp -9.314% -9.314% -57.670%
iShares Core DAX® -1.816% -2.419% 12.070%
iShares Nasdaq 100 4.333% 8.073% 32.493%
iShares Nikkei 225® 0.657% 1.234% 2.682%
iShares S&P 500 2.968% 4.613% 26.496%

According to BiotechBee what are the pros and cons of Anavex Life Sciences Corp for the foreseeable future?

Pros
Could be very worthwhile Investment >20% year
Cons

Comments by BiotechBee for this prediction

In the thread Anavex Life Sciences Corp diskutieren
Prediction Sell
Perf. (%) -2.34%
Target price 2.000
Change
Ends at 31.12.25

Sell mit Kursziel 2,0

In the thread Trading Anavex Life Sciences Corp
Prediction Sell
Perf. (%) -2.34%
Target price 2.000
Change
Ends at 31.12.25

Sell beendet

Stopped prediction by BiotechBee for Anavex Life Sciences Corp

Anavex Life Sciences Corp

Start price
Target price
Perf. (%)
€7.38
27.06.23
€2.00
31.12.26
-21.37%
13.10.23

Could be very worthwhile Investment >20% year